Cargando…
Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial
INTRODUCTION: Many extremely preterm newborns develop anaemia requiring a transfusion, with most receiving three to five transfusions during their admission. While transfusions save lives, the potential for transfusion-related adverse outcomes is an area of growing concern. Transfusion is an indepen...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373745/ https://www.ncbi.nlm.nih.gov/pubmed/37487676 http://dx.doi.org/10.1136/bmjopen-2022-070272 |
_version_ | 1785078625754677248 |
---|---|
author | Stark, Michael J Collins, Carmel T Andersen, Chad C Crawford, Tara M Sullivan, Thomas R Bednarz, Jana Morton, Rachael Marks, Denese C Dieng, Mbathio Owen, Louise S Opie, Gillian Travadi, Javeed Tan, Kenneth Morris, Scott |
author_facet | Stark, Michael J Collins, Carmel T Andersen, Chad C Crawford, Tara M Sullivan, Thomas R Bednarz, Jana Morton, Rachael Marks, Denese C Dieng, Mbathio Owen, Louise S Opie, Gillian Travadi, Javeed Tan, Kenneth Morris, Scott |
author_sort | Stark, Michael J |
collection | PubMed |
description | INTRODUCTION: Many extremely preterm newborns develop anaemia requiring a transfusion, with most receiving three to five transfusions during their admission. While transfusions save lives, the potential for transfusion-related adverse outcomes is an area of growing concern. Transfusion is an independent predictor of death and is associated with increased morbidity, length of hospital stay, risk of infection and immune modulation. The underlying mechanisms include adverse pro-inflammatory and immunosuppressive responses. Evidence supports an association between transfusion of washed red cells and fewer post-transfusion complications potentially through removal of chemokines, lipids, microaggregates and other biological response modifiers. However, the clinical and cost-effectiveness of washed cells have not been determined. METHODS AND ANALYSIS: This is a multicentre, randomised, double-blinded trial of washed versus unwashed red cells. Infants <28 weeks’ gestation requiring a transfusion will be enrolled. Transfusion approaches will be standardised within each study centre and will occur as soon as possible with a recommended fixed transfusion volume of 15 mL/kg whenever the haemoglobin is equal to or falls below a predefined restrictive threshold, or when clinically indicated. The primary outcome is a composite of mortality and/or major morbidity to first discharge home, defined as one or more of the following: physiologically defined bronchopulmonary dysplasia; unilateral or bilateral retinopathy of prematurity grade >2, and; necrotising enterocolitis stage ≥2. To detect a 10% absolute reduction in the composite outcome from 69% with unwashed red blood cell (RBCs) to 59% with washed RBCs with 90% power, requires a sample size of 1124 infants (562 per group). Analyses will be performed on an intention-to-treat basis with a prespecified statistical analysis plan. A cost-effectiveness analysis will also be undertaken. ETHICS AND DISSEMINATION: Ethics approval has been obtained from the Women’s and Children’s Health Network Human Research Ethics Committee (HREC/12/WCHN/55). The study findings will be disseminated through peer-reviewed articles and conferences. TRIAL REGISTRATION NUMBER: ACTRN12613000237785 Australian New Zealand Clinical Trials Registry. |
format | Online Article Text |
id | pubmed-10373745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-103737452023-07-28 Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial Stark, Michael J Collins, Carmel T Andersen, Chad C Crawford, Tara M Sullivan, Thomas R Bednarz, Jana Morton, Rachael Marks, Denese C Dieng, Mbathio Owen, Louise S Opie, Gillian Travadi, Javeed Tan, Kenneth Morris, Scott BMJ Open Paediatrics INTRODUCTION: Many extremely preterm newborns develop anaemia requiring a transfusion, with most receiving three to five transfusions during their admission. While transfusions save lives, the potential for transfusion-related adverse outcomes is an area of growing concern. Transfusion is an independent predictor of death and is associated with increased morbidity, length of hospital stay, risk of infection and immune modulation. The underlying mechanisms include adverse pro-inflammatory and immunosuppressive responses. Evidence supports an association between transfusion of washed red cells and fewer post-transfusion complications potentially through removal of chemokines, lipids, microaggregates and other biological response modifiers. However, the clinical and cost-effectiveness of washed cells have not been determined. METHODS AND ANALYSIS: This is a multicentre, randomised, double-blinded trial of washed versus unwashed red cells. Infants <28 weeks’ gestation requiring a transfusion will be enrolled. Transfusion approaches will be standardised within each study centre and will occur as soon as possible with a recommended fixed transfusion volume of 15 mL/kg whenever the haemoglobin is equal to or falls below a predefined restrictive threshold, or when clinically indicated. The primary outcome is a composite of mortality and/or major morbidity to first discharge home, defined as one or more of the following: physiologically defined bronchopulmonary dysplasia; unilateral or bilateral retinopathy of prematurity grade >2, and; necrotising enterocolitis stage ≥2. To detect a 10% absolute reduction in the composite outcome from 69% with unwashed red blood cell (RBCs) to 59% with washed RBCs with 90% power, requires a sample size of 1124 infants (562 per group). Analyses will be performed on an intention-to-treat basis with a prespecified statistical analysis plan. A cost-effectiveness analysis will also be undertaken. ETHICS AND DISSEMINATION: Ethics approval has been obtained from the Women’s and Children’s Health Network Human Research Ethics Committee (HREC/12/WCHN/55). The study findings will be disseminated through peer-reviewed articles and conferences. TRIAL REGISTRATION NUMBER: ACTRN12613000237785 Australian New Zealand Clinical Trials Registry. BMJ Publishing Group 2023-07-24 /pmc/articles/PMC10373745/ /pubmed/37487676 http://dx.doi.org/10.1136/bmjopen-2022-070272 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Paediatrics Stark, Michael J Collins, Carmel T Andersen, Chad C Crawford, Tara M Sullivan, Thomas R Bednarz, Jana Morton, Rachael Marks, Denese C Dieng, Mbathio Owen, Louise S Opie, Gillian Travadi, Javeed Tan, Kenneth Morris, Scott Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial |
title | Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial |
title_full | Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial |
title_fullStr | Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial |
title_full_unstemmed | Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial |
title_short | Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial |
title_sort | study protocol of the washt trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks’ gestation - a multicentre, blinded, parallel group, randomised controlled trial |
topic | Paediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373745/ https://www.ncbi.nlm.nih.gov/pubmed/37487676 http://dx.doi.org/10.1136/bmjopen-2022-070272 |
work_keys_str_mv | AT starkmichaelj studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT collinscarmelt studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT andersenchadc studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT crawfordtaram studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT sullivanthomasr studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT bednarzjana studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT mortonrachael studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT marksdenesec studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT diengmbathio studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT owenlouises studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT opiegillian studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT travadijaveed studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT tankenneth studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial AT morrisscott studyprotocolofthewashttrialtransfusionwithwashedversusunwashedredbloodcellstoreducemorbidityandmortalityininfantsbornlessthan28weeksgestationamulticentreblindedparallelgrouprandomisedcontrolledtrial |